Hence then, the article about immunic reports positive results from phase 1b clinical trial of imu 856 in celiac disease providing clinical proof of concept for new therapeutic approach to gastrointestinal disorders was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders )
Also on site :
- Lanes blocked in northwest suburban intersection after multi-vehicle crash
- Trump administration efforts to shift blame for ICE shooting wreak havoc on Minnesota US attorney’s office
- New Trailer for 'The Beauty' With Ashton Kutcher Has Fans Obsessed — And Sets a Record